Enteric coated ddI approved: FDA letter.
D016049:Didanosine / Q000008:administration & dosage; D017277:Drug Approval; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D013608:Tablets, Enteric-Coated; D014481:United States; D014486:United States Food and Drug Administration
D018894:Reverse Transcriptase Inhibitors; D013608:Tablets, Enteric-Coated; D016049:Didanosine